A major result of this study is the identification of a combination of two CpGs, one CpG in the promoter (CpG07504598) and one CpG in the gene body (CpG12922093) of DFNA5, which was able to discriminate between primary breast adenocarcinomas and normal breast samples. The gene discussed is GSDME; the disease is breast adenocarcinoma.